- Home
- QVCGP vs HUMAW Comparison
QVCGP vs HUMAW Comparison
Compare QVCGP & HUMAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QVCGP
- HUMAW
- Stock Information
- Founded
- QVCGP N/A
- HUMAW 2004
- Country
- QVCGP
- HUMAW United States
- Employees
- QVCGP 18900
- HUMAW 220
- Industry
- QVCGP
- HUMAW Biotechnology: Pharmaceutical Preparations
- Sector
- QVCGP
- HUMAW Health Care
- Exchange
- QVCGP NYSE
- HUMAW Nasdaq
- Market Cap
- QVCGP N/A
- HUMAW N/A
- IPO Year
- QVCGP N/A
- HUMAW N/A
- Fundamental
- Price
- QVCGP $6.27
- HUMAW $0.48
- Analyst Decision
- QVCGP
- HUMAW
- Analyst Count
- QVCGP 0
- HUMAW 0
- Target Price
- QVCGP N/A
- HUMAW N/A
- AVG Volume (30 Days)
- QVCGP N/A
- HUMAW 14.2K
- Earning Date
- QVCGP N/A
- HUMAW 03-21-2025
- Dividend Yield
- QVCGP N/A
- HUMAW N/A
- EPS Growth
- QVCGP N/A
- HUMAW N/A
- EPS
- QVCGP N/A
- HUMAW N/A
- Revenue
- QVCGP N/A
- HUMAW N/A
- Revenue This Year
- QVCGP N/A
- HUMAW N/A
- Revenue Next Year
- QVCGP N/A
- HUMAW N/A
- P/E Ratio
- QVCGP N/A
- HUMAW N/A
- Revenue Growth
- QVCGP N/A
- HUMAW N/A
- 52 Week Low
- QVCGP N/A
- HUMAW $1.18
- 52 Week High
- QVCGP N/A
- HUMAW $1.34
- Technical
- Relative Strength Index (RSI)
- QVCGP N/A
- HUMAW N/A
- Support Level
- QVCGP N/A
- HUMAW N/A
- Resistance Level
- QVCGP N/A
- HUMAW N/A
- Average True Range (ATR)
- QVCGP 0.00
- HUMAW 0.00
- MACD
- QVCGP 0.00
- HUMAW 0.00
- Stochastic Oscillator
- QVCGP 0.00
- HUMAW 0.00
About QVCGP QVC GROUP INC 8.0% FIXED RATE CUM RED PFD STK
QVC Group Inc is a live social shopping company with six retail brands QVC, HSN, Ballard Designs, Frontgate, Garnet Hill, Grandin Road, and other minority interests. QVC offers assortment of ,quality merchandise and classifies its products into six groups: home, apparel, beauty, accessories, electronics and jewelry. The company has three reportable segments: QxH, QVC International, and CBI. Majority of revenue is from Home products, from QxH segment. Company also operates in Japan, Germany and Other foreign countries.
About HUMAW Humacyte Inc. Warrant
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.